| Home | E-Submission | Sitemap | Contact Us |  
logo
Korean J Med > Volume 93(3); 2018 > Article
2018 대한부정맥학회 비판막성 심방세동 환자의 뇌졸중 예방 지침
Korean J Med 2018;93:87-109. https://doi.org/10.3904/kjm.2018.93.2.87
다음과 같이 본문 내 Table 5에 오류가 있어 수정합니다.

Table 5.
Guidance for temporary interruption of NOAC before surgery
Dabigatran
Apixaban, edoxaban, rivaroxaban
Low-risk surgery High-risk surgery
Low-risk surgery High-risk surgery
Creatinine clearance >80 mL/min 24 hours 48 hours 24 hours 48 hours
Creatinine clearance 50-80 mL/min 36 hours 72 hours 24 hours 48 hours
Creatinine clearance 30-50 mL/min 48 hours 96 hours 24 hours 48 hours
Creatinine clearance 15-30 mL/min Not indicated Not indicated 36 hours 48 hours

NOAC, non-vitamin K antagonist oral anticoagulant.

Table 5.
Guidance for temporary interruption of NOAC before surgery
Dabigatran
Apixaban, edoxaban, rivaroxaban
Low risk surgery High risk surgery Low risk surgery High risk surgery
Creatinine clearance >80 mL/min 24 hours 48 hours 24 hours 48 hours
Creatinine clearance 50-80 mL/min 36 hours 72 hours 24 hours 48 hours
Creatinine clearance 30-50 mL/min 48 hours 96 hours 24 hours 48 hours
Creatinine clearance 15-30 mL/min Not indicated Not indicated 36 hours 48 hours

NOAC, non-vitamin K antagonist oral anticoagulant.

Editorial Office
101-2501, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-2271-6791   Fax: +82-2-790-0993    E-mail: kaim@kams.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Association of Internal Medicine. All rights reserved.                powerd by m2community